Skip to main content
SpringerLink
Log in

ACE inhibitors for the treatment of myocardial ischemia?

  • Review Section
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Apart from their established use in the treatment of hypertension and heat failure, ACE inhibitors have been suggested to exert anti-ischemic effects. This article reviews the mechanisms of systemic and intracardiac angiotensin formation, as well as its interaction with the bradykinin, the prostaglandin, and the sympathetic nervous system. While high doses of angiotensin can precipitate myocardial ischemia, experimental data on a potential beneficial effect of ACE inhibitors on ischemic myocardial blood flow and function are inconsistent and controversial. Pooling the few available clinical data, several ACE inhibitors may attenuate myocardial ischemia at rest and during exercise. However, a significant fraction of patients does not benefit or even deteriorates. Recent experimental studies suggest a beneficial role of ACE inhibitors in attenuating reperfusion arrhythmias and postinfarction left ventricular remodeling. Unless the mechanisms and determinants of potential anti-ischemic actions of ACE inhibitors can be better defined, their use for treatment of myocardial ischemia cannot be recommended at present.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dzau VJ. ACE inhibitors in hypertension: A US perspective.Cardiology 1989;76(Suppl 2):23–30.

    Google Scholar 

  2. Schoenberger JA. Emerging benefits of angiotensin converting enzyme inhibitors versus other antihypertensive agents.Am J Med 1988;84(Suppl 4A):30–35.

    Google Scholar 

  3. Waeber B, Nussberger J, Brunner HR. Angiotensin converting enzyme inhibition in arterial hypertension.Wien Med Wschr 1990;1/2:22–29.

    Google Scholar 

  4. Zannad F, Gilgenkrantz J.-M. ACE inhibitors in hypertension: A European viewpoint.Cardiology 1989;76(Suppl 2):31–41.

    PubMed  Google Scholar 

  5. Chatterjee K, Opie LH. Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure.Cardiovasc Drugs Ther 1987;1:1–8.

    PubMed  Google Scholar 

  6. Massie BM. New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure.Am J Med 1988;84(Suppl 4A):36–46.

    Google Scholar 

  7. Reid JL. Present aspects and future developments with ACE inhibitors.Cardiology 1989;76(Suppl 2):1–10.

    Google Scholar 

  8. Riegger AJG. ACE inhibitors in congestive heart failure.Cardiology 1989;76(Suppl 2):42–49.

    Google Scholar 

  9. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham.Am J Cardiol 1976;37:269–282.

    PubMed  Google Scholar 

  10. Kirchheim HR, Ehmke H, Hackenthal E, et al. Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs.Pflügers Arch 1987;410:441–449.

    Google Scholar 

  11. Kirchheim HR, Finke R, Hackenthal E, et al. Baroreflex sympathetic activation increases threshold pressure for the pressure-dependent renin release in conscious dogs.Pflügers Arch 1985;405:127–135.

    Google Scholar 

  12. Poulsen K, Poulsen LL. Simultaneous determination of plasma converting enzyme and angiotensinase activity by radioimmunoassay.Clin Sci 1971;40:443–449.

    PubMed  Google Scholar 

  13. Yang HYT, Erdös EG. Second kininase in human blood plasma.Nature 1967;215:1402–1403.

    PubMed  Google Scholar 

  14. Yang HYT, Erdös EG, Levin Y. Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme).J Pharmacol Exp Ther 1971;177:291–300.

    PubMed  Google Scholar 

  15. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.J Clin Invest 1986;78:31–39.

    PubMed  Google Scholar 

  16. Cushman DW, Cheung HS. Concentrations of angiotensinconverting enzyme in tissues of the rat.Biochim Biophys Acta 1971;250:261–265.

    PubMed  Google Scholar 

  17. Dzau VJ, Re RN. Evidence for the existence of renin in the heart.Circulation 1987;75(Suppl I):I134-I136.

    PubMed  Google Scholar 

  18. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.Circulation 1988;77(Suppl I):I4-I13.

    PubMed  Google Scholar 

  19. Kifor I, Dzau VJ. Endothelial renin-angiotensin pathway: Evidence for intracellular synthesis and secretion of angiotensins.Circ Res 1987;60:422–428.

    PubMed  Google Scholar 

  20. Lilly LS, Pratt RE, Alexander RW, et al. Renin expression by vascular endothelial cells in culture.Circ Res 1985;57:312–318.

    PubMed  Google Scholar 

  21. Re R, Fallon JT, Dzau V, et al. Renin synthesis by canine aortic smooth muscle cells in culture.Life Sci 1982;30:99–106.

    PubMed  Google Scholar 

  22. Lindpaintner K, Jin M, Wilhelm MJ, et al. Intracardiac generation of angiotensin and its physiologic role.Circulation 1988;77(Suppl I):I18-I23.

    PubMed  Google Scholar 

  23. Needleman P, Marshall GR, Sobel BE. Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin.Circ Res 1975;37:802–808.

    PubMed  Google Scholar 

  24. Britton S, Di Salvo J. Effects of angiotensin I and angiotensin II on hindlimb and coronary vascular resistance.Am J Physiol 1973;225:1226–1231.

    PubMed  Google Scholar 

  25. Noguchi K, Kato T, Ito H, et al. Effect of intracoronary captopril on coronary blood flow and regional myocardial function in dogs.Eur J Pharmacol 1985;110:11–19.

    PubMed  Google Scholar 

  26. Boulanger C, Hendrickson H, Lorenz RR, et al. Release of different relaxing factors by cultured porcine endothelial cells.Circ Res 1989;64:1070–1078.

    PubMed  Google Scholar 

  27. Kelm M, Schrader J. Nitric oxide release from the isolated guinea pig heart.Eur J Pharmacol 1988;155:317–321.

    PubMed  Google Scholar 

  28. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.Nature 1987;327:524–526.

    PubMed  Google Scholar 

  29. Kimura E, Hashimoto K, Furukawa S, et al. Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery.Am Heart J 1973;85:635–647.

    PubMed  Google Scholar 

  30. Berger HJ, Zaret BL, Speroff L, et al. Cardiac prostaglandin release during myocardial ischemia induced by atrial pacing in patients with coronary artery disease.Am J Cardiol 1977;39:481–486.

    PubMed  Google Scholar 

  31. Bassenge E, Heusch G. Endothelial and neurohumoral control of coronary blood flow in health and disease.Rev Physiol Biochem Pharmacol 1990;in press.

  32. Bergman G, Atkinson L, Richardson PJ, et al. Prostacyclin: Haemodynamic and metabolic effects in patients with coronary artery disease.Lancet 1981:569–572.

  33. Szczeklik A, Szczeklik J, Nizankowski R, et al. Prostacyclin for acute coronary insufficiency.Artery 1980;8:7–11.

    PubMed  Google Scholar 

  34. Siegel RJ, Shah PK, Nathan M, et al. Prostaglandin E1 infusion in unstable angina: Effects on anginal frequency and cardiac function.Am Heart J 1984;108:863–868.

    PubMed  Google Scholar 

  35. Chierchia S, Patrono C, Crea F, et al. Effects of intravenous prostacyclin in variant angina.Circulation 1982; 65:470–477.

    PubMed  Google Scholar 

  36. de Jonge A, Thoolen MJMC, Timmermans PBMWM. Interaction of angiotensin converting enzyme inhibitors with the sympathetic nervous system.Prog Pharamcol 1984;5/3:25–38.

    Google Scholar 

  37. de Jonge A, Wilffert B, Kalkman HO, et al. Captopril impairs the vascular smooth muscle contraction mediated by postsynaptic α2-adrenoceptors in the pithed rat.Eur J Pharmacol 1981;74:385–386.

    PubMed  Google Scholar 

  38. Dunn WR, McGrath JC, Wilson VG. Expression of functional postjunctional α2-adrenoceptor in rabbit isolated distal saphenous artery—a permissive role for angiotensin II?Br J Pharmacol 1989;96:259–261.

    PubMed  Google Scholar 

  39. Heusch G. α-Adrenergic mechanisms in myocardial ischemia.Circulation 1990;81:1–13.

    PubMed  Google Scholar 

  40. Carlsson L, Abrahamsson T. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.Eur J Pharmacol 1989;166:157–164.

    PubMed  Google Scholar 

  41. de Graeff PA, van Gilst WH, de Langen CDJ, et al. Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heart.Arch Int Pharmacodyn 1986;280:181–193.

    PubMed  Google Scholar 

  42. van Gilst WH, de Graeff PA, Wesseling H, et al. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: A comparison of captopril, enalapril, and HOE 498.J Cardiovasc Pharmacol 1986;8:722–728.

    Google Scholar 

  43. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system.J Hypertension 1984;2:581–587.

    Google Scholar 

  44. Isaacson JS, Reid IA. Importance of endogenous angiotensin II in the cardiovascular responses to sympathetic stimulation in conscious rabbits.Circ Res 1990;66:662–671.

    PubMed  Google Scholar 

  45. Cohen MV, Kirk ES. Differential response of large and small coronary arteries to nitroglycerin and angiotensin.Circ Res 1973;33:445–453.

    PubMed  Google Scholar 

  46. Ertl G. Coronary vasoconstriction in experimental myocardial ischemia.J Cardiovasc Pharmacol 1987;9(Suppl 2):S9-S17.

    PubMed  Google Scholar 

  47. Brum JM, Sufan Q, Dewey J, et al. Effects of angiotensin and ergonovine on large and small coronary arteries in the intact dog.Basic Res Cardiol 1985;80:333–342.

    PubMed  Google Scholar 

  48. Gavras H, Kremer D, Brown JJ, et al. Angiotensin- and norepinephrine-induced myocardial lesions: Experimental and clinical studies in rabbits and man.Am Heart J 1975;89:321–332.

    PubMed  Google Scholar 

  49. Gould KL. Dynamic coronary stenosis.Am J Cardiol 1980;45:286–292.

    PubMed  Google Scholar 

  50. Berdeaux A, Bonhenry C, Giudicelli JF. Effects of four angiotensin I converting enzyme inhibitors on regional myocardial blood flow and ischemic injury during coronary artery occlusion in dogs.Fundam Clin Pharmacol 1987;1:201–212.

    PubMed  Google Scholar 

  51. Ertl G, Alexander RW, Kloner RA. Interactions between coronary occlusion and the renin-angiotensin system in the dog.Basic Res Cardiol 1983;78:518–533.

    PubMed  Google Scholar 

  52. Liang C-S, Gavras H, Black J, et al. Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size.Circulation 1982;66:1249–1255.

    PubMed  Google Scholar 

  53. van Gilst WH, Scholtens E, de Graeff PA, et al. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.Circulation 1988;77(Suppl I):I24-I29.

    PubMed  Google Scholar 

  54. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.Circ Res 1989;65:1–21.

    PubMed  Google Scholar 

  55. Alam S, Rezkalla S, Farkas P, et al. Does captopril ameliorate myocardial ischemia during coronary balloon occlusion? (abstract)Circulation 1989;80(Suppl II):II52.

    Google Scholar 

  56. Heusch G, Deussen A. The effects of cardiac sympathetic nerve stimulation on the perfusion of stenotic coronary arteries in the dog.Circ Res 1983;53:8–15.

    PubMed  Google Scholar 

  57. Chatterjee K, Rouleau J-L, Parmley WW, Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.Br Heart J 1982;47:233–238.

    PubMed  Google Scholar 

  58. Daly P, Rouleau J-L, Cousineau D, et al. Acute effects of captopril on the coronary circulation of patients with hypertension and angina.Am J Med 1984;31:111–115.

    Google Scholar 

  59. Daly P, Mettauer B, Rouleau J-L, et al. Lack of reflex increase in myocardial sympathetic tone after captopril: Potential antianginal effect.Circulation 1985;71:317–325.

    PubMed  Google Scholar 

  60. Halperin JL, Faxon DP, Creager MA, et al. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.Am J Cardiol 1982;50:967–972.

    PubMed  Google Scholar 

  61. Mettauer B, Rouleau J-L, Daly P. The effect of captopril on the coronary circulation and myocardial metabolism of patients with coronary artery disease.Postgrad Med J 1986;62(Suppl 1):54–58.

    PubMed  Google Scholar 

  62. Rouleau J-L, Chatterjee K, Benge W, et al. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: A comparative study.Circulation 1982; 65:671–678.

    PubMed  Google Scholar 

  63. Strozzi C, Cocco G, Portaluppi F, et al. Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris.Cardiology 1987;74: 226–228.

    PubMed  Google Scholar 

  64. Gibbs JSR, Crean PA, Mockus L, et al. The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.Br Heart J 1989;62:112–117.

    PubMed  Google Scholar 

  65. Bussmann W-D, Goerke S, Schneider W, et al. Angiotensin converting enzyme inhibitor in angina.Dtsch Med Wschr 1988;113:548–550.

    PubMed  Google Scholar 

  66. Keck M. Anti-ischaemic effect of captopril in patients with stable angina pectoris.Herz-Kreisl 1987;19:319–321.

    Google Scholar 

  67. Tardieu A, Virot P, Vandroux JC, et al. Effects of captopril on myocardial perfusion in patients with coronary insufficiency: Evaluation by the exercise test and quantitative myocardial tomoscintigraphy using thallium-201.Postgrad Med J 1986;62(Suppl 1):38–41.

    PubMed  Google Scholar 

  68. Gasic S, Dudczak R, Korn A, et al. ACE inhibition with cilazapril improves myocardial perfusion to the ischemic regions during exercise: Aplot study.J. Cardiovasc Pharmacol 1990;15:227–232.

    PubMed  Google Scholar 

  69. Lai C, Onnis E, Orani E, et al. Antiischaemic activity of ACE inhibitor enalapril in normotensive patients with stable effort angina (abstract).J. Am Coll Cardiol 1987;9:192A.

    Google Scholar 

  70. Rietbrock N, Thürmann P, Kirsten R, et al. Anti-ischaemic effect of enalapril in coronary heart disease. A randomized, placebo-conalapril in coronary heart disease. A randomized, placebo-controlled double blind trial on 12 patients.Dtsch Med Wschr 1988;113:300–302.

    PubMed  Google Scholar 

  71. Unterberg C, Buchwald A, Vogt A, et al. Akute Effekte des Angiotensin-Converting-Enzym-Hemmers Ramipril bei Patienten mitkoronarer Herzerkrankung.Med Klin 1990;85:78–81.

    PubMed  Google Scholar 

  72. Rousseau MF, Close P, Pouleur H, Are the angiotensinconverting enzyme inhibitors poor anti-ischemicdrugs? (abstract)Circulation 1989;80(Suppl II):II52.

    Google Scholar 

  73. Webster MWI, Fitzpatrick MA, Nicholls MG, et al. Effect of enalapril on ventricular arrhythmias in congestive heart failure.Am J Cardiol 1985;56:566–569.

    PubMed  Google Scholar 

  74. Cleland JGF, Dargie HJ, Hodsman GP, et al. Captopril in heart failure. A double blind contralled trial.Br Heart J 1984;52:530–535.

    PubMed  Google Scholar 

  75. Linz W, Schölkens BA, Manwen J, et al. The hear as a target for converting enzyme inhibitors: Studies in ischaemic isolate working rat hearts.J Hypertension 1986;4(Suppl 6):S477-S479.

    Google Scholar 

  76. Linz W, Schölkens BA. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.J Cardiovasc Pharmacol 1987; 10(Suppl 7):S75-S82.

    Google Scholar 

  77. van Gilst WH, de Graeff PA, Kingma JH, et al. Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion.Eur J Pharmacol 1984;100:113–117.

    Google Scholar 

  78. Li K, Chen X. Protective effects of captopric and enalapril on myocardial ischemia and reperfusion damage of rat.J. Mol Cell Cardiol 1987;19:909–915.

    PubMed  Google Scholar 

  79. Rochette L, Ribuot C, Belichard P, et al. Protective effect of angiotensin converting enyme inhibitors (CEI): Captopril and perindopril on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion in rat.Clin Exp Theory and Practice 1987;A9:365–368.

    Google Scholar 

  80. Liz W, Schölkens BA, Kaiser J, et al. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the convertingenzyme inhibitor ramipril.Cardiovasc Drugs Ther 1989; 3:873–882.

    PubMed  Google Scholar 

  81. Schölkens BA, Linz W., Lindpaintener K, et al. Angiotensin deteriorates but bradykinin improves cardiac function following ischeamia in isolated rat hearts.J. Hypertension 1987;5(Suppl 5):S7-S9.

    Google Scholar 

  82. Dargie HJ, McAlipine HM, Morton JJ, Neuroendocrine activation in acute myocardial infarction.J Cardiovasc Pharmacol 1987;9(Suppl 2):S21-S24.

    PubMed  Google Scholar 

  83. Lefer AM, Peck RC. Cardioprotective effects ofenalapril in acute myocardial ischemia.Pharmacology 1984;29:61–69.

    PubMed  Google Scholar 

  84. Hock CE, Ribeiro LGT. Lefer AM. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilicacid, in acute myocardial infarction.Am Heart J 1985;109:222–228.

    PubMed  Google Scholar 

  85. Ertl G, Kloner RA, Alexander RW, et al. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.Circulation 1982;56:40–48.

    Google Scholar 

  86. Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: Results of the NHLBI cooperative study. Comparison of unconscious and conscious dog models.Circ Res 1985;56:651–665.

    PubMed  Google Scholar 

  87. Daniell HB, Carson RR, Ballard KD, et al. Effects of captopril on limiting infarct size in conscious dogs.J Cardiovasc Pharmacol 1984;6:1043–1047.

    PubMed  Google Scholar 

  88. Erlebacher JA, Weiss JL, Eaton LW, et al. Late effects of acute infarct dilation on heart size: A two dimensional echocardiographic study.Am J Cardiol 1982;49:1120–1126.

    PubMed  Google Scholar 

  89. Hutchins GM, Bulkley BH. Infarct expanion versus extension: Two different complications ofacute myocardial infarction.Am J Cardiol 1978;41:1127–1132.

    PubMed  Google Scholar 

  90. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling after myocardial infarction: A corollary to infarct expansion.Circulation 1986;74:693–702.

    PubMed  Google Scholar 

  91. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Circ Res 1985;57:84–95.

    PubMed  Google Scholar 

  92. Pfeffer MA, Pfeffer JM, Steinberg C. et al. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril.Circulation 1985;72:406–412.

    PubMed  Google Scholar 

  93. Sharpe N, Murphy J, Smith H, et al. Treatment of patients with symptoless left ventricular dysfunction after myocardial infarction.Lancet 1988;1:255–259.

    PubMed  Google Scholar 

  94. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.Circulation 1987;76:44–51.

    PubMed  Google Scholar 

  95. Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.N Engl J Med 1988;319:80–86.

    PubMed  Google Scholar 

  96. Eaton LW, Weiss JL, Bulkley BH, et al. Regional cardiac dilatation after acute myocardial infarction. Recognition by two-dimensional echocardiography.N Engl J Med 1979; 300:57–62.

    PubMed  Google Scholar 

  97. Neyses L, Williams RS, Sukhatme VP, et al. Direkte Wirkung des Angiotensin II (AII) auf Genexpression im Myokard-Hinweis auf Hypertrophieinduktion durch AII (abstract).Z Kardiol 1990;79(Suppl 1):34.

    Google Scholar 

  98. Aceto JF, Baker KM. Sarl langiotensin II receptormediated stimulation of protein synthesis in chick heart cells.Am J Physiol 1990;258:H806-H813.

    PubMed  Google Scholar 

  99. Drexler H, Lindpaintner K, Lu W, et al. Aktivierung des kardialen Renin-Angiotensin-Systems (RAS) nach experimentellem Infarkt (abstract).Z Kardiol 1990;79(Suppl 1):42.

    Google Scholar 

  100. Hall AS, Ball SG, AIRE Study Research Group. ACE inhibitors after myocardial infarction.Lancet 1989;23/30:1527.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für pathophysiologie, Zentrum für Innere Medizin, Universitätsklinikum Essen, Hufelandstr. 55, 4300, Essen, FRG

    Christa Linder &  Gerd Heusch

Authors
  1. Christa Linder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerd Heusch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linder, C., Heusch, G. ACE inhibitors for the treatment of myocardial ischemia?. Cardiovasc Drug Ther 4, 1375–1384 (1990). https://doi.org/10.1007/BF02018265

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02018265

Key Words

Search

Navigation